LINC02613

Across TCGA pan-cancer cohorts, LINC02613 RNA differs between tumor and matched normal tissue in 14 of 18 cancer types tested, making tumor–normal expression one of LINC02613’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC02613 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02613 is over-expressed in tumor, although a few such as KIRC and COAD show the opposite, repressed pattern.

KIRC, COAD, and BRCA are the cancer types where LINC02613 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02613 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	IV	−0.673	<.001	12	view →
COAD	All	II,III,IV	−0.437	<.001	10	view →
BRCA	All	III,IV	−2.961	<.001	8	view →
BLCA	All	III,IV	−0.769	<.001	8	view →
LIHC	All	All	+0.204	<.001	7	view →
UCEC	All	III,IV	−1.609	<.001	6	view →
STAD	All	All	−0.540	<.001	6	view →
KIRP	All	All	−0.375	<.001	5	view →
HNSC	Male	All	−0.636	.014	4	view →
READ	All	All	−0.757	.008	3	view →
LUSC	All	All	+0.437	.001	3	view →
THCA	All	All	−0.227	.001	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 14 lineages.

LINC02613–KIRC

Open the KIRC breakdown →